对于低危非肌层浸润性膀胱癌经尿道切除术后无法进行膀胱内化疗单次灌注的情况，是否应推荐持续膀胱冲洗？
Should continuous bladder irrigation be recommended when single instillation of intravesical chemotherapy cannot be used after transurethral resection in low-risk non-muscle invasive bladder cancer?
作者信息
Chemi Joaquin, Villoldo Gustavo Martin
机构信息
Urology Department, Instituto Alexander Fleming, Cramer 1180, (1426) Ciudad Autónoma de Buenos Aires, Argentina.
出版信息
Bladder (San Franc). 2023 Mar 17;10:e21200002. doi: 10.14440/bladder.2023.848. eCollection 2023.
Abstract
Reducing the recurrence rate in patients with low-risk non-muscle invasive bladder cancer patients is a critical concern in the urologic community. The gold standard treatment is single instillation (SI) of intravesical chemotherapy after transurethral resection of bladder tumor (TURBT), but unfortunately, it is underused. Continuous bladder irrigation (CBI) after TURBT is an alternative strategy to SI for the prevention of bladder tumor implantation and recurrence. The aim of this review was to present the evidence that supports CBI after TURBT when SI is not possible.
摘要
降低低风险非肌层浸润性膀胱癌患者的复发率是泌尿外科领域的一个关键问题。金标准治疗方法是在经尿道膀胱肿瘤切除术（TURBT）后进行膀胱内化疗单剂量灌注（SI），但遗憾的是，这种方法未得到充分应用。TURBT术后持续膀胱冲洗（CBI）是一种替代SI的策略，用于预防膀胱肿瘤种植和复发。本综述的目的是阐述在无法进行SI时支持TURBT术后CBI的证据。
相似文献
1
Should continuous bladder irrigation be recommended when single instillation of intravesical chemotherapy cannot be used after transurethral resection in low-risk non-muscle invasive bladder cancer?
Bladder (San Franc). 2023 Mar 17;10:e21200002. doi: 10.14440/bladder.2023.848. eCollection 2023.
2
Continuous bladder irrigation after transurethral resection of non-muscle invasive bladder cancer for prevention of tumour recurrence: a systematic review.
ANZ J Surg. 2021 Dec;91(12):2592-2598. doi: 10.1111/ans.16740. Epub 2021 Apr 23.
3
The role of continuous saline bladder irrigation after transurethral resection in patients with high-grade non-muscle-invasive bladder cancer.
Scand J Urol. 2018 Oct-Dec;52(5-6):385-388. doi: 10.1080/21681805.2018.1548502. Epub 2019 Jan 10.
4
[Value of European Organisation for Research and Treatment of Cancer score system for predication of immediate postoperative intravesical instillation of pirarubicin after transurethral resection of non-muscle invasive bladder cancer].
Zhonghua Zhong Liu Za Zhi. 2018 Apr 23;40(4):308-312. doi: 10.3760/cma.j.issn.0253-3766.2018.04.014.
5
[The intravesical recurrence after 3-day consecutive intravesical instillation of pirarubicine hydrochloride (THP) following transurethral resection of bladder tumor (TURBT) for non-muscle-invasive bladder cancer].
Nihon Hinyokika Gakkai Zasshi. 2012 Jul;103(4):610-6. doi: 10.5980/jpnjurol.103.610.
6
Effect of continuous saline bladder irrigation with concomitant single instillation of chemotherapy after transurethral resection on intravesical recurrence in patients with non-muscle-invasive bladder cancer.
Mol Clin Oncol. 2020 Sep;13(3):6. doi: 10.3892/mco.2020.2079. Epub 2020 Jun 25.
7
Continuous saline bladder irrigation after blue light transurethral resection of bladder tumor increases recurrence-free survival in low- to intermediate-risk non-muscle invasive bladder cancer.
Prog Urol. 2021 May;31(6):316-323. doi: 10.1016/j.purol.2021.01.011. Epub 2021 Mar 2.
8
Double-Blind, Randomized, Placebo-controlled Studies Evaluating Apaziquone (E09, Qapzola™) Intravesical Instillation Post Transurethral Resection of Bladder Tumors for the Treatment of Low-risk Non-Muscle Invasive Bladder Cancer.
Bladder Cancer. 2018 Jul 30;4(3):293-301. doi: 10.3233/BLC-180166.
9
Electromotive instillation of mitomycin immediately before transurethral resection for patients with primary urothelial non-muscle invasive bladder cancer: a randomised controlled trial.
Lancet Oncol. 2011 Sep;12(9):871-9. doi: 10.1016/S1470-2045(11)70190-5. Epub 2011 Aug 8.
10
Prospective randomized controlled trial of postoperative early intravesical chemotherapy with pirarubicin (THP) for solitary non-muscle invasive bladder cancer comparing single and two-time instillation.
World J Urol. 2018 Jun;36(6):889-895. doi: 10.1007/s00345-018-2196-8. Epub 2018 Jan 31.
本文引用的文献
1
Trial-based Cost-effectiveness Analysis of an Immediate Postoperative Mitomycin C Instillation in Patients with Non-muscle-invasive Bladder Cancer.
Eur Urol Open Sci. 2022 Jan 17;37:7-13. doi: 10.1016/j.euros.2021.12.008. eCollection 2022 Mar.
2
Post-Transurethral Resection of Bladder Tumor Bladder Perforation Resulting in Mitomycin C Extravasation, Pudendal Neuralgia, and Ureterohydronephrosis.
J Endourol Case Rep. 2020 Dec 29;6(4):315-318. doi: 10.1089/cren.2020.0117. eCollection 2020.
3
Meta-analysis of efficacy and safety of continuous saline bladder irrigation compared with intravesical chemotherapy after transurethral resection of bladder tumors.
World J Urol. 2019 Jun;37(6):1075-1084. doi: 10.1007/s00345-019-02628-7. Epub 2019 Jan 5.
4
Bladder irrigation after transurethral resection of superficial bladder cancer: a systematic review of the literature.
Can J Urol. 2018 Dec;25(6):9579-9584.
5
Continuous saline bladder irrigation for two hours following transurethral resection of bladder tumors in patients with non-muscle invasive bladder cancer does not prevent recurrence or progression compared with intravesical Mitomycin-C.
BMC Urol. 2018 Oct 24;18(1):93. doi: 10.1186/s12894-018-0408-6.
6
Overnight continuous saline irrigation after transurethral resection for non-muscle-invasive bladder cancer is helpful in prevention of early recurrence.
Can Urol Assoc J. 2018 Nov;12(11):E480-E483. doi: 10.5489/cuaj.5122. Epub 2018 Jun 8.
7
Effect of Intravesical Instillation of Gemcitabine vs Saline Immediately Following Resection of Suspected Low-Grade Non-Muscle-Invasive Bladder Cancer on Tumor Recurrence: SWOG S0337 Randomized Clinical Trial.
JAMA. 2018 May 8;319(18):1880-1888. doi: 10.1001/jama.2018.4657.
8
Randomized controlled study of the efficacy and safety of continuous saline bladder irrigation after transurethral resection for the treatment of non-muscle-invasive bladder cancer.
BJU Int. 2017 Feb;119(2):276-282. doi: 10.1111/bju.13599. Epub 2016 Aug 18.
9
EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.
Eur Urol. 2017 Mar;71(3):447-461. doi: 10.1016/j.eururo.2016.05.041. Epub 2016 Jun 17.
10
Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa-pT1 Urothelial Carcinoma of the Bladder: Which Patients Benefit from the Instillation?
Eur Urol. 2016 Feb;69(2):231-44. doi: 10.1016/j.eururo.2015.05.050. Epub 2015 Jun 16.
Zotero 插件